4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-003876
Chairman & CEO sold 19,875 shares at an average $77.61 ($1,542,513)
- Chairman & CEO acquired 29,375 shares (option exercise)
- Chairman & CEO gave 105,905 shares (gift)
- Chairman & CEO gave 105,905 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
MUSSALLEM MICHAEL A · Chairman & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-15 | Gift : show line 1 in the form | −96,405 | 60,947.82 | D | ||
| 2023-03-14 | Exercise or conversion : show line 2 in the form | +29,375 | $35.20 | $1,033,903 | 90,322.82 | D |
| 2023-03-14 | Sale : show line 3 in the form | −9,175 | $77.32 | $709,411 | 81,147.82 | D |
| 2023-03-14 | Gift : show line 4 in the form | −9,500 | 71,647.82 | D | ||
| 2023-03-14 | Sale : show line 5 in the form | −10,700 | $77.86 | $833,102 | 60,947.82 | D |
| 2023-02-15 | Gift : show line 6 in the form | +96,405 | 3,588,422 | I | ||
| 2023-03-14 | Gift : show line 7 in the form | +9,500 | 3,597,922 | I | ||
| Open-market sales · 19,875 sh · avg $77.61 · $1,542,513 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-03-14 | Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Acquire) | −29,375 | $35.20 | 2023-05-11 | 29,375 | 58,750 | D |
Loading xslF345X03/doc4.xml…